Evidence map›Paper›PMID 34168441›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2021

Clinical Features and Antimicrobial Susceptibility of

Ko-Yun Chang, Pi-Chu Wu, Ching-Hsiao Lee, Yu-Che Lee, Hui-Chen Chen, Wei-Chang Huang, Ming-Feng Wu

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Prevalence and risk factors ofF1000Research · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ko-Yun Chang *Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Pi-Chu Wu *Nursing Department, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Ching-Hsiao LeeDepartment of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, 350, Taiwan.
Yu-Che LeeDepartment of Medicine, University at Buffalo-Catholic Health, Buffalo, NY, USA.ORCID 0000-0001-8418-7228
Hui-Chen ChenDivision of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Wei-Chang Huang *Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan.ORCID 0000-0002-9733-5899
Ming-Feng Wu *Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, 407, Taiwan.
Taichung Veterans General Hospital · TWKang-Ning Junior College of Medical Care and Management · TWNational Chung Hsing University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Little is known about the features and implications of Patients and Methods: In this retrospective, cross-sectional study, clinical data from medical records were reviewed and collected for analysis. Results: Of the 262 participants, 17.2% (45/262), 11.5% (30/262), and 27.1% (71/262) had PA, ABC, and any of the two isolates discovered from EA cultures, respectively. Patients with PA isolates were associated with poorer lung function (the Global Initiative for Chronic Obstructive Lung Disease (GOLD) III+IV versus GOLD I+II, odds ratio (OR)=2.39, p= 0.022) and a lower body mass index (per increase of 1 kg/m Conclusion: Our findings provide important information to help intensivists make better treatment decisions in critically ill patients with COPD and CAP.

Indexed as

Acinetobacter baumanniiPneumoniaPulmonary Disease, Chronic ObstructiveAnti-Bacterial AgentsCritical CareCross-Sectional StudiesHumansIntensive Care UnitsMicrobial Sensitivity TestsPseudomonas aeruginosaRetrospective StudiesTaiwanAnti-Bacterial AgentsAcinetobacter baumannii complexCAPCOPDintensive carePseudomonas aeruginosaTaiwan

Identifiers

PMID34168441
PMCPMC8216665
OpenAlexW3166561293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.